Literature DB >> 11063800

Losses of heterozygosity in endometrial adenocarcinomas: positive correlations with histopathological parameters.

S M Sirchia1, E Sironi, F R Grati, P Serafini, I Garagiola, F Rossella, F Dulcetti, G Pardi, S Garsia, G Simoni.   

Abstract

We analyzed 37 samples of endometrial adenocarcinoma for loss of heterozygosity (LOH) by using a panel of 44 microsatellites located in 29 chromosomal regions. The aim of our study was to investigate the existence of a possible preferential involvement of some tumor suppressor genes in endometrial carcinogenesis. The analysis was performed on tumoral tissue and on a corresponding normal tissue by the use of polymerase chain reaction (PCR) and the comparison of the amplified alleles. We observed significative LOH (>20%) in the chromosomal regions of 2q14 (33.33%), 7q35 (24.00%), 10q22.1 (37. 50%), 11q13-q14 (44.12%), 15q26 (40.63%), 17p13 (25.71%), and 17q21. 3 (37.04%). We defined a 1-cM minimal common deletion in 11q13-q14 between D11S911 and D11S937 markers. A statistical analysis revealed a positive correlation between LOH of 11q13-q14 and clinicopathological data.

Entities:  

Mesh:

Year:  2000        PMID: 11063800     DOI: 10.1016/s0165-4608(00)00240-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Malignant tumors and forensics--dilemmas and proposals.

Authors:  Zoran Budimlija; Connie Lu; Grace Axler-DiPerte; Jessica Seifarth; Dorota Popiolek; Franz Fogt; Mechthild Prinz
Journal:  Croat Med J       Date:  2009-06       Impact factor: 1.351

2.  p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.

Authors:  Andrzej Semczuk; Carsten Boltze; Barbara Marzec; Anna Szczygielska; Albert Roessner; Regine Schneider-Stock
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-14       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.